GABAA agonist reduces visual awareness: a masking-EEG experiment

Area of Science:

• Neuroscience
• Cognitive Science
• Psychology

Background:

• Consciousness manipulation can occur via visual masking and pharmacological interventions.
• Understanding shared neural pathways for these manipulations is crucial for cognitive neuroscience.

Purpose of the Study:

• To investigate if visual masking and pharmacological agents share common neural mechanisms in altering visual consciousness.
• To compare the effects of dextromethorphan, lorazepam (LZP), and scopolamine on visual awareness during a masking task.

Main Methods:

• Electroencephalography (EEG) recorded from participants performing a backward-masking task with varying strengths.
• Within-subject administration of dextromethorphan, lorazepam (LZP), scopolamine, and placebo.
• Analysis of behavioral detection rates and event-related potential (ERP) signals.

Main Results:

• Detection rates decreased with increased masking strength; only LZP further reduced detection.
• An intermediate neural event (156-211 msec) in the perioccipital cortex was reduced by both masking and LZP.
• This intermediate neural event correlated significantly with behavioral detection performance.

Conclusions:

• Visual masking and lorazepam (LZP) reduce visual awareness via a shared mechanism modulating late visual cortex activity.
• Early visual activation remains unaffected by these interventions, suggesting specific downstream effects.
• These findings offer the first evidence for a common pathway in manipulating visual consciousness through distinct methods.